Skip to main content

Cyntellect to Perform Cell-Based Assays for Japanese Pharma Company

NEW YORK, March 30 (GenomeWeb News) - Cyntellect will analyze compounds from Japanes drug maker Daiichi Pharmaceutical using its high-throughput cell imaging and laser-based cell-manipulation technology, the company said today.

 

Under the agreement, San Diego-based Cyntellect will use its Leap technology to design, configure, and run cell-based assays against a compound collection from Daiichi.

 

Cyntellect did not disclose financial terms of the collaboration.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.